Paul Hargreaves
Corporate Officer/Principal presso SPAGO NANOMEDICAL AB
Profilo
Paul Hargreaves is currently the Chief Development Officer at Spago Nanomedical AB since 2021.
Prior to this, he worked at LEO Pharma.
A as the Head-Global Clinical Operations & Vice President.
Posizioni attive di Paul Hargreaves
| Società | Posizione | Inizio |
|---|---|---|
| SPAGO NANOMEDICAL AB | Corporate Officer/Principal | 13/09/2021 |
Precedenti posizioni note di Paul Hargreaves
| Società | Posizione | Fine |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SPAGO NANOMEDICAL AB | Health Technology |
| Aziende private | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Paul Hargreaves
